Products authorised in Türkiye
Inpharmus commercialises innovative oncology and rare disease treatments in Türkiye. Below you will find each product with its active substance and the approved product documents.
Therapeutic area
SmPC — Summary of Product Characteristics (KÜB)·PIL — Patient Information Leaflet (KT). Documents are the versions approved by the Turkish Medicines and Medical Devices Agency.